Sign up Australia
Proactive Investors - Run By Investors For Investors
Why invest in MED?
Medgold Resources Corp: THE INVESTMENT CASE

Medgold Resources excited by potential of Serbia project ahead of drilling

Medgold has earmarked drilling to start at the Tlamino project in Serbia in August
Medgold Resources excited by potential of Serbia project ahead of drilling
INVESTMENT OVERVIEW: MED The Big Picture
Medgold is exploring in Serbia

Gold explorer Medgold Resources Corp (CVE:MED) is looking at a busy and exciting summer, as it pushes ahead with drilling and thereby potentially de-risking the Tlamino project in Serbia.

It has lined up a contractor, is going through final hurdles, and a 2,500 metre drill program is earmarked to start at the end of this summer initially to test high grade areas it has identified.

The property includes two historical showings - Liska and Barje - and the IP survey work identified an anomaly which extends to the west of the Barje outcrop for over 1km, which will also be drill tested.

Channel sampling has also thrown up high grades, for example an overall intersection of 84 metres (m) at 5.6 g/t gold at Barje.

Dan James, the president at Medgold recently told Proactive: "I haven't seen many projects around with grade like that, siting at surface. You can't walk away."

WATCH - Medgold boss on 'tantalising' potential at Tlamino after encouraging results

What assets does Medgold Resources have?

The Europe-focused group is partnered with Centerra in Portugal, which fully funds its work, and in Serbia, it has struck a strategic alliance with Fortuna Silver Mines Inc.

The main project in Portugal was Boticas but after several years, and having not discovered a 1mln ounce target, the firm has stepped back efforts in the country to focused wholly on Serbia.

There, Fortuna, which has a 24% stake in Medgold and it's the largest shareholder,  has chosen  Tlamino as the first project to option.

Essentially, the deal sees Fortuna financing exploration on a select small portfolio of projects and then electing or not to progress further with whatever looks good in a formal joint venture

It can earn up to 70% of two chosen projects by spending $8mln on exploration and completing a preliminary economic assessment (PEA).

Registering interest in many licences.

Notably, Medgold already has six licences granted in Serbia and had registered interest in around 20 more, so  it really has hit the ground aggressively in the country, which is currently enjoying a  new wave of mining industry interest.

Capital Network's mining analyst Sam Catalano says he likes the fact that Medgold has joined with a larger partner across its Serbian asset base to ensure it’s a ‘well-funded exploration vehicle’.

"As a broad comment, this can provide potential Medgold investors with some comfort that they will not be asked to contribute meaningful equity to support exploration efforts.

"The flip-side is that to some extent investors upside in the main projects is capped (typically at ~30% of asset value), however, in a time of low equity prices in the sector, and general difficulty for early stage exploration funding, we believe this shows good savvy from the management team to push their efforts forward."





Register here to be notified of future MED Company articles
View full MED profile View Profile

Medgold Resources Corp Timeline

Related Articles

Intermin Resources: Access latest PPT from Proactive's CEO Sessions
April 13 2017
Jon Price talked funding drilling program in world-class region with investors.
Pioneer Resources: Access latest PPT from Proactive's CEO Sessions
June 19 2017
David Crook talked cash from caesium with investors.
Wolf quarterlies highlight progress with Hemerdon tungsten project
January 31 2017
Wolf has restructured debt and secured a firmer hold on its operating Hemerdon tungsten project in Devon

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use